By: Benzinga
UPDATE: J.P. Morgan Raises PT on Onyx Pharmaceuticals on Palbo Incorporation
In a report published Thursday, J.P. Morgan analyst Cory Kasimov reiterated an Overweight rating on Onyx Pharmaceuticals (NASDAQ: ONXX ), and raised the price target from $100.00 to $105.00. In the report, Kasimov noted, “We are reiterating our OW rating on ONXX (one of our top picks) and bumping our
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here